Flexible Work, Better Balance
Ellipses Pharma is a global clinical-stage drug development company focused on progressing first- or best-in-class oncology drugs. Ellipsesβ maturing clinical pipeline is progressing three clinical phase-2 programmes with an additional programme due to commence Phase 1 studies in 2026.
Ellipses Pharma is supported by a global Scientific Advisory Group comprising over 300 leading Oncology Key Opinion Leaders to de-risk initial asset selection and provide critical insights into clinical trial design.
The Medical Director has primary responsibility for providing medical expertise and oversight to all aspects of the ongoing asset development programmes from protocol design through to safety oversight (pharmacovigilance), and the interpretation and presentation of emerging clinical data in alignment with agreed asset strategy. The Medical Director will be responsible for building and representing deep understanding of the e...